Assessment of Automated Breast Ultrasound
NCT02386176 is an observational study sponsored by University of Pittsburgh. As of 21 Nov 2026, it is completed. It studies Breast Cancer. The registry lists an enrollment of 598 participants at 1 site in 1 country. The registry lists a start date of 31 Aug 2015 and a primary completion date of 31 Mar 2020.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02386176 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | University of Pittsburgh |
| Enrollment | 598 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Breast Cancer |
| Start | 31 Aug 2015 |
| Primary completion | 31 Mar 2020 |
| Study completion | 31 Mar 2020 |
| Last update posted | 6 Apr 2020 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Denise M Chough, MD
University of Pittsburgh
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Magee-Womens Hospital
Pittsburgh
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02386176
Each answer restates registry values shown on this page.
What is NCT02386176?
NCT02386176 is an observational study sponsored by University of Pittsburgh. It studies Breast Cancer.
Who leads NCT02386176?
The registry names Denise M Chough, MD (principal investigator, University of Pittsburgh) as the overall official.
Where does NCT02386176 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT02386176 end?
The registry lists a primary completion date of 31 Mar 2020 and a study completion date of 31 Mar 2020. The sponsor last updated the record on 6 Apr 2020.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.